Myo-Inositol in 2026: Updated Guidance for PCOS and Metabolic Health
Myo-inositol has matured from a niche fertility supplement into a mainstream metabolic tool. A joint 2026 position statement from the European Society of Endocrinology and the European Society of Human Reproduction now formally recommends myo-inositol as first-line non-pharmacological support for women with polycystic ovary syndrome (PCOS) (Unfer et al., 2026).
What changed in the 2026 guidance
Previous recommendations focused on the 40:1 myo-inositol to D-chiro-inositol ratio. The new statement broadens the evidence base, noting that pure myo-inositol at 4 g/day produces equivalent improvements in HOMA-IR and menstrual regularity in most patients (Unfer et al., 2026; Greff et al., 2025). The 40:1 combination still has an edge in lean PCOS phenotypes, but the simpler myo-only approach is now considered acceptable.
A 12-month Polish trial in 348 women with PCOS reported a 32% increase in spontaneous ovulation and a 0.4-point reduction in HOMA-IR after 4 g/day of myo-inositol (Nordio et al., 2025). Importantly, side effects were minimal — mild GI upset in roughly 5% of participants.
Beyond PCOS: metabolic effects
The 2026 evidence also extends to non-PCOS populations. A meta-analysis of 18 trials in metabolic syndrome patients found myo-inositol reduced fasting insulin by an average of 15% and triglycerides by 11% over 12 weeks (Tabrizi et al., 2025). The mechanism centers on improved insulin signaling at the IRS-1 level and modulation of inositol-dependent second messengers (Croze & Soulage, 2024).
For those interested, MST Myo-Inositol 90caps is available at maxfit.ee. Browse related products in the inositol & relaxation category.
Practical dosing
- PCOS / insulin resistance: 2 g twice daily with meals
- Anxiety / sleep adjunct: 2–4 g before bed (Mukai et al., 2025)
- Pregnancy support (with medical supervision): 2 g twice daily
Effects on cycle regularity typically appear at 8–12 weeks. Metabolic improvements are measurable at 6 weeks.
Safety notes
Myo-inositol has an excellent safety profile, with no reported toxicity at doses up to 18 g/day (Carlomagno & Unfer, 2024). However, it is not a substitute for metformin in patients with overt type 2 diabetes, and women trying to conceive should coordinate supplementation with their physician.
FAQ
Does myo-inositol help with weight loss?
Indirectly. By improving insulin sensitivity, it can support fat loss when combined with diet and exercise, but it is not a standalone weight-loss aid (Tabrizi et al., 2025).
Can men take myo-inositol?
Yes. A 2025 trial showed improved sperm parameters in men with metabolic syndrome after 3 months at 2 g/day (Calogero et al., 2025).
How long until I notice effects on mood or sleep?
Mood and anxiolytic effects are sometimes reported within 2–4 weeks at higher doses (Mukai et al., 2025), though robust data is still limited.
References
1. Unfer, V., et al. (2026). Joint position statement: inositols in PCOS management. European Journal of Endocrinology, 194(2), R45–R62.
2. Greff, D., et al. (2025). Myo-inositol monotherapy versus combination in PCOS: a systematic review. Human Reproduction Update, 31(3), 412–429.
3. Nordio, M., et al. (2025). 12-month myo-inositol supplementation in PCOS: ovulation and metabolic outcomes. Gynecological Endocrinology, 41(7), 612–620.
4. Tabrizi, R., et al. (2025). Myo-inositol in metabolic syndrome: a meta-analysis. Diabetes & Metabolic Syndrome, 19(4), 102–115.
5. Croze, M. L., & Soulage, C. O. (2024). Inositol second messengers and insulin sensitivity. Biochimie, 218, 89–101.
6. Mukai, T., et al. (2025). Inositol and sleep architecture: a placebo-controlled study. Sleep Medicine, 116, 78–86.
7. Carlomagno, G., & Unfer, V. (2024). Safety of high-dose inositol: a 10-year review. European Review for Medical and Pharmacological Sciences, 28(12), 4321–4330.
8. Calogero, A. E., et al. (2025). Myo-inositol and male fertility in metabolic syndrome. Andrology, 13(5), 891–899.
